Literature DB >> 7853487

Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.

D C Ansardi1, C D Morrow.   

Abstract

The assembly of infectious poliovirus virions requires a proteolytic cleavage between an asparagine-serine amino acid pair (the maturation cleavage site) in VP0 after encapsidation of the genomic RNA. In this study, we have investigated the effects that mutations in the maturation cleavage site have on P1 polyprotein processing, assembly of subviral intermediates, and encapsidation of the viral genomic RNA. We have made mutations in the maturation cleavage site which change the asparagine-serine amino acid pair to either glutamine-glycine or threonine-serine. The mutations were created by site-directed mutagenesis of P1 cDNAs which were recombined into wild-type vaccinia virus to generate recombinant vaccinia viruses. The P1 polyproteins expressed from the recombinant vaccinia viruses were analyzed for proteolytic processing and assembly defects in cells coinfected with a recombinant vaccinia virus (VV-P3) that expresses the poliovirus 3CD protease. A trans complementation system using a defective poliovirus genome was utilized to assess the capacity of the mutant P1 proteins to encapsidate genomic RNA (D. C. Ansardi, D. C. Porter, and C. D. Morrow, J. Virol. 67:3684-3690, 1993). The mutant P1 proteins containing the glutamine-glycine amino acid pair (VP4-QG) and the threonine-serine pair (VP4-TS) were processed by 3CD provided in trans from VV-P3. The processed capsid proteins VP0, VP3, and VP1 derived from the mutant precursor VP4-QG were unstable and failed to assemble into subviral structures in cells coinfected with VV-P3. However, the capsid proteins derived from VP4-QG did assemble into empty-capsid-like structures in the presence of the defective poliovirus genome. In contrast, the capsid proteins derived from processing of the VP4-TS mutant assembled into subviral intermediates both in the presence and in the absence of the defective genome RNA. By a sedimentation analysis, we determined that the capsid proteins derived from the VP4-TS precursor encapsidated the defective genome RNA. However, the cleavage of VP0 to VP4 and VP2 was delayed, resulting in the accumulation of provirions. The maturation cleavage of the VP0 protein containing the VP4-TS mutation was accelerated by incubation of the provirions at 37 degrees C. The results of these studies demonstrate that mutations in the maturation cleavage site have profound effects on the subsequent capability of the capsid proteins to assemble and provide evidence for the existence of the provirion as an assembly intermediate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853487      PMCID: PMC188747     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

Review 1.  Maturation of poliovirus capsid proteins.

Authors:  C U Hellen; E Wimmer
Journal:  Virology       Date:  1992-04       Impact factor: 3.616

2.  Temperature-sensitive poliovirus mutant fails to cleave VP0 and accumulates provirions.

Authors:  S R Compton; B Nelsen; K Kirkegaard
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  Further evidence on the formation of poliovirus proteins.

Authors:  M F Jacobson; J Asso; D Baltimore
Journal:  J Mol Biol       Date:  1970-05-14       Impact factor: 5.469

4.  RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus.

Authors:  N E Bishop; D A Anderson
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

5.  Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome.

Authors:  W M Lee; S S Monroe; R R Rueckert
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

6.  Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Expression of poliovirus P3 proteins using a recombinant vaccinia virus results in proteolytically active 3CD precursor protein without further processing to 3Cpro and 3Dpol.

Authors:  D C Porter; D C Ansardi; M R Lentz; C D Morrow
Journal:  Virus Res       Date:  1993-09       Impact factor: 3.303

8.  Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.

Authors:  D C Ansardi; C D Morrow
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more
  14 in total

1.  Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus.

Authors:  Amy L Odegard; Kartik Chandran; Xing Zhang; John S L Parker; Timothy S Baker; Max L Nibert
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  Poliovirus 2C region functions during encapsidation of viral RNA.

Authors:  L M Vance; N Moscufo; M Chow; B A Heinz
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Uncoating of common cold virus is preceded by RNA switching as determined by X-ray and cryo-EM analyses of the subviral A-particle.

Authors:  Angela Pickl-Herk; Daniel Luque; Laia Vives-Adrián; Jordi Querol-Audí; Damià Garriga; Benes L Trus; Nuria Verdaguer; Dieter Blaas; José R Castón
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

4.  Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4.

Authors:  M Hindiyeh; Q H Li; R Basavappa; J M Hogle; M Chow
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.

Authors:  Ke Lyu; Guang-Chuan Wang; Ya-Ling He; Jian-Feng Han; Qing Ye; Cheng-Feng Qin; Rong Chen
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

6.  Dynamics and stability in maturation of a T=4 virus.

Authors:  Jinghua Tang; Kelly K Lee; Brian Bothner; Timothy S Baker; Mark Yeager; John E Johnson
Journal:  J Mol Biol       Date:  2009-07-20       Impact factor: 5.469

7.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

8.  Insight into poliovirus genome replication and encapsidation obtained from studies of 3B-3C cleavage site mutants.

Authors:  Hyung Suk Oh; Harsh B Pathak; Ian G Goodfellow; Jamie J Arnold; Craig E Cameron
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

9.  Analysis of picornavirus 2A(pro) proteins: separation of proteinase from translation and replication functions.

Authors:  H H Lu; X Li; A Cuconati; E Wimmer
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating.

Authors:  Kristin L Shingler; Jennifer L Yoder; Michael S Carnegie; Robert E Ashley; Alexander M Makhov; James F Conway; Susan Hafenstein
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.